destroy potential oxidants, and to scavenge ROS. Thus, A simple, automated test measuring the ferric reduc-oxidative stress-induced tissue damage is minimized. ing ability of plasma, the FRAP assay, is presented as However, an absolute or relative deficiency of antioxia novel method for assessing ''antioxidant power.'' Fer-dant defenses may lead to a situation of increased oxiric to ferrous ion reduction at low pH causes a colored dative stress, and this may be associated with both ferrous-tripyridyltriazine complex to form. FRAP val-the causes and consequences of a variety of disorders, ues are obtained by comparing the absorbance change including coronary heart disease and cancer (6-13).
A biological antioxidant has been defined as ''any putative index of antioxidant, or reducing, potential substance that, when present at low concentrations of biological fluids within the technological reach of compared to those of an oxidisable substrate, signifievery laboratory and researcher interested in oxida-cantly delays or prevents oxidation of that substrate'' tive stress and its effects. ᭧ 1996 Academic Press, Inc. (20) . This definition is clear and covers every member of the antioxidant defense team. However, unless an antioxidant prevents the generation of ROS, for example, by metal chelation or enzyme-catalyzed removal of Potentially harmful reactive oxygen species (ROS) 2 a potential oxidant (1, 2), a redox reaction still occurs. are produced as a consequence of normal aerobic me-
The difference is that the oxidizing species reacts with tabolism (1, 2). These ''free radicals'' are usually rethe antioxidant instead of the ''substrate,'' i.e., the antimoved or inactivated in vivo by a team of antioxidants oxidant reduces the oxidant. In simple terms then, non-(1-5). Individual members of the antioxidant defense enzymatic antioxidants such as ascorbic acid can be team are deployed to prevent generation of ROS, to described as reductants, and inactivation of oxidants by reductants can be described as redox reactions in 1 To whom correspondence should be addressed. Fax: 852 which one reactive species is reduced at the expense of ity. This being the case, a method using reductants in Approval for this work was obtained from the Ethics Subcommittee of Hong Kong Polytechnic University. a redox-linked colorimetric method employing an easily reduced oxidant in stoichiometric excess could offer a Antioxidants. Solid L-(/)-ascorbic acid extra pure simple way of assessing this ability. crystals (Merck, Germany), uric acid, solid (BDH), alThe method described measures the ferric reducing bumin, solid (bovine serum albumin, fraction V, ability of plasma (FRAP). At low pH, when a ferric-Sigma), bilirubin calibrator solution (Sigma), and Trotripyridyltriazine (Fe III -TPTZ) complex is reduced to lox (Aldrich Chemical Co., U.S.A.) were used to prethe ferrous (Fe   II   ) form, an intense blue color with an pare aqueous antioxidant solutions. DL-a-Tocopherol absorption maximum at 593 nm develops (21, 22) . The (Merck) was diluted in ethanol (Merck). reaction is nonspecific, and any half-reaction which has
Reagent kits (Hoffman-LaRoche Ltd., Switzerland). a less-positive redox potential, under reaction condi-Uric acid was measured by an enzymatic method, bilitions, than the Fe III /Fe II -TPTZ half-reaction will drive rubin was measured by an alkaline picrate method, Fe III -TPTZ reduction. Test conditions favor reduction of and albumin was measured by a bromocresol green the complex and, thereby, color development, provided dye-binding method. These tests were performed on a that a reductant (antioxidant) is present. Ferrozine Cobas Fara centrifugal analyzer (Roche) following the (23), a compound closely related to TPTZ, has been manufacturer's instructions and using commercially widely used, with excess ascorbic acid, to measure iron. available calibrators and quality control samples. In the FRAP assay, excess Fe III is used, and the rateAutomated FRAP assay. A Cobas Fara centrifugal limiting factor of Fe II -TPTZ, and hence color, formation analyzer was used to perform the FRAP assay as folis the reducing ability of the sample.
lows: 300 ml freshly prepared FRAP reagent was The FRAP assay is described, and results are pre-warmed to 37ЊC and a reagent blank reading was taken sented with particular reference to the following: reac-(M1) at 593 nm; 10 ml of sample was then added, along tion kinetics and dose-response relationships with so-with 30 ml H 2 O; final dilution of sample in reaction lutions of ascorbic acid, uric acid, bilirubin, Trolox (a mixture was, therefore, 1/34. Absorbance (A) readings water-soluble analog of vitamin E), a-tocopherol, and were taken after 0.5 s and every 15 s thereafter during albumin, with mixtures of these antioxidants and with the monitoring period. The change in absorbance plasma; relative activities of these reductants (referred (DA 593nm ) between the final reading selected and the to in this paper as antioxidants in line with current M1 reading was calculated for each sample and related usage of the term) and possible interaction between to DA 593nm of a Fe II standard solution tested in parallel. them; within-run and between-run precision of the In this study the reaction was monitored for up to 8 assay; FRAP values of fresh plasma from normal, min, but the 4-min readings were selected for calculahealthy, Chinese adults.
tion of FRAP values; reasons for this are discussed in a later section. Results presented for uric acid, albu-
MATERIALS AND METHODS
min, and bilirubin are the measured concentrations. Trolox, a-tocopherol, Fe II , and ascorbic acid concentraReagent preparation. Reagents included 300 mmol/ tions given are the calculated concentrations. All soluliter acetate buffer, pH 3.6 (3.1 g C 2 H 3 NaO 2 r3H 2 O (Rietions were used on the day of preparation; ascorbic acid del-de Haen, Germany) and 16 ml C 2 H 4 O 2 (BDH solutions were used within 1 h of preparation. Bovine Laboratory Supplies, England) per liter of buffer soluserum albumin concentrations were converted from tion); 10 mmol/liter TPTZ (2,4,6-tripyridyl-s-triazine, grams per liter to micromoles per liter concentrations Fluka Chemicals, Switzerland) in 40 mmol/liter HCl using a molecular mass of 68,000. (BDH); 20 mmol/liter FeCl 3 r6H 2 O (BDH). Working FRAP reagent was prepared as required by mixing 25 RESULTS ml acetate buffer, 2.5 ml TPTZ solution, and 2.5 ml FeCl 3 r6H 2 O solution.
The FRAP assay gives fast, reproducible results with plasma, with single antioxidants in pure solution and Samples. Aqueous solutions of known Fe II concentration, in the range of 100-1000 mmol/liter (FeS-with mixtures of antioxidants in aqueous solution and added to plasma. The dose-response characteristics of O 4 7H 2 O; Riedel de Haen), were used for calibration. Fresh EDTA plasma from 141 consenting, healthy Chi-different antioxidants showed different activities, but the dose response of each individual antioxidant tested nese 21-74 years of age (mean 42 years) was chilled and assayed within 5 h of collection. ''Aged plasma'' was linear, showing that activity is not concentrationdependent, at least over the concentration ranges was EDTA plasma that had been pooled and stored at 070ЊC for at least 2 months; aliquots were thawed as tested in this study. The relative activity was 2.0; i.e., direct reaction of Fe II gave a change in absorbance half required and used as a between-run precision sample. All procedures involving human subjects complied with that of an equivalent molar concentration, for Trolox, a-tocopherol, ascorbic acid, and uric acid. The activity the Declaration of Helsinki of 1975, as revised in 1983.
squares, bilirubin (50 mmol/liter) corrected for the albumin-associated absorbance changes (and reagent blank-corrected). Results indicate that the continued, slow increase in absorbance seen in the reaction of the bilirubin calibrator is due to its albumin content, and that the reaction of bilirubin is complete by 4 min after sample-reagent mixing. The 0-to 4-min reaction time window, therefore, is suitable for the measurement of bilirubin's contribution to FRAP, as well as that of the other antioxidants tested.
When , and albumin (plus sign). Each point represents the mean of four of bilirubin was around 4.0, while that of albumin was very low. There did not appear to be any interaction absorbance readings from four separate runs. Readings were highly reproducible, with the SD in every case between the antioxidants tested that either enhanced or dampened antioxidant activity in this system. £0.02; therefore the {1 SD error bars, though present in Fig. 3 , do not show. The dose-response lines of a- Figure 1 shows the rate of increase in absorbance at 593 nm for 100 mmol/liter solutions of bilirubin (crossed tocopherol and Trolox were indistinguishable from each other and are both represented by a common symsquares), ascorbic acid (filled squares), uric acid (triangles), a-tocopherol (open circles), and albumin (plus bol (open circle). The linear dose response obtained for sign) compared to the monitored absorbance of reagent only (diamonds), all measured in parallel. The reaction with ascorbic acid and alpha tocopherol is very fast, reaching completion in under 1 min. The reaction with uric acid reaches an endpoint after 3 min. The reactions with the bilirubin preparation and with albumin do not reach an endpoint within the monitoring period, although the reaction of bilirubin is fast in the first few seconds and relatively slow by 2 min post-sample/ reagent mixing. Glucose was tested but did not react in this system.
Because the Sigma bilirubin calibrator contains albumin (19 g/liter, 280 mmol/liter), the albumin contribution to absorbance readings of the bilirubin calibrator was explored. An aqueous solution of bovine serum albumin of 280 mmol/liter was prepared and the FRAP reaction of this solution was monitored. The albuminassociated absorbance changes were then subtracted from those of the bilirubin calibrator run in parallel, and the albumin-corrected bilirubin absorbance changes inspected. Results are shown in Table 2 . The difference due to centrifugation is negligible, and while there is a statistically significant difference between the water-and acetate buffer-diluted samples, the difference is small, at around 5 g/liter (75 mmol/liter). Thus, albumin remains in solution but has a very low reactivity in the FRAP assay, probably due to a low pH effect on protein thiol groups.
When known amounts of individual antioxidants were mixed and the FRAP value was measured, there was good recovery (91-112%). Good agreement was seen between the anticipated, by calculation, and measured FRAP values (r Å 0.990; P õ 0.001) after known amounts of individual antioxidants were added to plasma (Fig. 4, filled circles) and to water (Fig. 4, open  circles) . In addition, the FRAP dose-response relationship was the same; i.e., parallel lines were obtained, ( Fig. 5, filled triangles) the presence of 100 mmol/liter ascorbic acid, and when different concentrations of ascorbic acid were tested with and without 200 mmol/ liter uric acid (results not shown). These results all each individual antioxidant implies that the stoichiometric factors, or antioxidant activities, of these antiox-indicate that there is no activity-changing antioxidant interaction in this test system. idants are not concentration-dependent in this system. However, the relative activities of the individual antiWithin-run coefficients of variation (CV) were õ1.0% at all FRAP values tested (100, 200, and 900 mmol/ oxidants in this system are not all the same. Relative to the reaction of Fe II (representing a one electron ex-liter; n Å 10 in each case). Between-run CV was õ3.0% (mean 960 mmol/liter; n Å 25). The mean (median; SD) change reaction and taken as unity), and using the 0-to 4-min reaction time window, activities of bilirubin, plasma FRAP value of 141 apparently healthy Chinese adults was 1017 (1000; 206) mmol/liter (range, 612-ascorbic acid, uric acid, a-tocopherol, Trolox, and albumin were calculated by comparing the amount of any 1634 mmol/liter). There was a significant correlation between the FRAP values and the plasma uric acid given antioxidant with the amount of Fe II required to give the same absorbance change. Calculated activities concentrations (r Å 0.914, P õ 0.001; n Å 141). of the various antioxidant tested are given in Table 1 ; DISCUSSION for a-tocopherol (and Trolox) and ascorbic acid, activities were very close to 2.0 at all concentrations tested.
The FRAP assay is quick and simple to perform, and the reaction is reproducible and linearly related to the The activity of uric acid was slightly greater than 2.0. This is thought to be within allowable limits of experimental error, but some uric acid may be oxidized fur- allowing the diluted samples to stand at room tempera- molar concentration of the antioxidant(s) present. and high chloride concentration of the reaction mixture (25) . In addition, the small, in absolute terms, physioThere is no activity-changing interaction between antioxidants in this system nor, as has been reported (24), logical variations in plasma iron (õ10 mmol/liter), which may occur within and between individuals, are are stoichiometric factors concentration-dependent. Reaction mixtures containing plasma show no decrease unlikely to affect results. While the presence of large amounts of a strong iron chelator in plasma could theoin absorbance up to at least 30 min post-reagent/sample mixing (results not shown), indicating that there is retically affect results, it should be noted there is an excess of free Fe III in the FRAP reagent. Free iron has no process or agent causing inhibition of Fe III reduction or causing Fe II reoxidation. It should be noted that, a relatively low redox potential (26) , and is unlikely to take part in the indicator redox reaction provided the while ceruloplasmin in plasma has ferroxidase activity, it is unlikely to be active in FRAP due to the low pH more oxidizing Fe III -TPTZ is present. In addition, it is thought unlikely that the situation would arise in protecting the liver and gut from oxidative damage and may act as a reserve or backup system, augwhereby sufficient Fe III (or Fe II ) could be stripped from TPTZ by a chelator present in the biological sample menting defenses when other antioxidants are lacking or depleted by oxidative stress. being tested. However, if the test was performed in the presence of large amounts of an iron chelator, then
As in other tests of oxidative stress and antioxidant defense, FRAP reaction conditions are far from physioincreasing the amount of Fe III in the reagent would probably prevent chelation interference.
logical, and it must be noted that in vitro testing of plasma may not reflect in vivo hierarchies or activities In the FRAP assay, the 0-to 4 min reaction time window was used, as this encompasses the uric acid-, (20, 26) . The clinical utility of measuring antioxidant, or reducing, power in biological fluids remains to be a-tocopherol-, ascorbic acid-, and bilirubin-related absorbance changes. Albumin reacts very slowly and its established. Nevertheless, the FRAP assay appears to be an attractive and potentially useful test. Reagents activity is low. This may be advantageous, in that FRAP values can be measured without a blanket of are inexpensive, the procedure is speedy and straightforward, results are highly reproducible over a wide protein-associated absorbance changes muffling smaller, and perhaps more important, changes due to concentration range, and the equipment required is of a type commonly found in biochemical laboratories. variations in other antioxidants in the sample. There is a relatively large amount of albumin in plasma Clinical studies, comparing different population groups, measuring changes in FRAP values associated (around 700 mmol/liter) and albumin may act as a sacrificial antioxidant in vivo (1-4). However, its role in with particular pathological states and monitoring FRAP values during various treatment strategies, are antioxidant defense is unclear, and oxidative change in proteins may be a specific marker of oxidative dam-now needed. These are being planned, and will be supported by the data on the substantial number of norage (1-3, 8, 27) rather than a sign of antioxidant defense.
mal, apparently healthy Chinese adults presented here. In addition, because the test lends itself to the Results of this study show that FRAP values of apparently healthy Chinese adults are around 1 mmol/ measurement of reducing power in fluids other than plasma, extracts of drugs, plants, herbs, and other diliter (range 0.6-1.6 mmol/liter) and correlate directly and significantly with plasma uric acid concentrations. etary factors can now also be studied with relative ease.
To conclude, therefore, the FRAP assay offers a putaThis correlation has been reported by others (18, 28) and uric acid may have an important role in antioxi-tive index of antioxidant defense of potential use to and within the technological reach of every laboratory and dant defense (29-31) and participate in recycling of antioxidants (31-34). Using measured plasma uric researcher interested in oxidative stress and its effects. acid concentrations (not shown) and a relative activity of 2.0, uric acid is estimated to contribute around 60% ACKNOWLEDGMENTS to the FRAP value of fresh plasma. Using the measured Sincere thanks go to Professor E. D. Janus for his helpful comor expected plasma concentrations and relative activi-ments and advice. Trolox used was kindly supplied by Dr. C. W. K. ties of the other antioxidants in plasma (35, 36) , the Lam. This work was financially supported by Hong Kong Polytechnic estimated relative contributions to the FRAP value of University. fresh plasma are 15, 5, 10, and 5% for ascorbic acid, atocopherol, protein, and bilirubin, respectively. These REFERENCES total and relative figures are similar to those of previ- tioxidant power (14-19, 37, 38) . system, double that of ascorbic acid, uric acid, and a- 
